The present invention is directed to indazole and azaindazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.
-
(2021/01/29)
INDAZOLES AS LRRK2 INHIBITORS
The present invention is directed to indazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.
-
Page/Page column 84; 197
(2020/10/09)
FUSED TETRAZOLES AS LRRK2 INHIBITORS
The present invention is directed to fused tetrazoles of formula (IA) which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.
-
(2019/12/04)
SUBSTITUTED INDAZOLE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
Provided herein are methods for treating and preventing malaria and/or Babesiosis, the methods comprising administering an effective amount of Indazole Compounds having the formulas: (I)[Formula (I) should be inserted here] or (II)[Formula (II) should be inserted here] wherein R1, R2, R3 and Y are as defined herein.
-
Paragraph 00193
(2016/06/28)
POLYCYCLIC INDAZOLE DERIVATIVES THAT ARE ERK INHIBITORS
Disclosed are the ERK inhibitors of formula 1.0 and the pharmaceutically acceptable salts and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.
-
Page/Page column 193
(2008/06/13)
Rho KINASE INHIBITORS
-
-
(2010/02/06)
More Articles about upstream products of 478837-59-1